NDC 53002-1687

LYZA

Norethindrone

LYZA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Rpk Pharmaceuticals, Inc.. The primary component is Norethindrone.

Product ID53002-1687_19ac3421-1296-4bf7-afea-de4771da9bb4
NDC53002-1687
Product TypeHuman Prescription Drug
Proprietary NameLYZA
Generic NameNorethindrone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-06-24
Marketing CategoryANDA / ANDA
Application NumberANDA200980
Labeler NameRPK Pharmaceuticals, Inc.
Substance NameNORETHINDRONE
Active Ingredient Strength0 mg/1
Pharm ClassesProgesterone Congeners [CS],Progestin [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 53002-1687-1

28 TABLET in 1 POUCH (53002-1687-1)
Marketing Start Date2017-09-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53002-1687-1 [53002168701]

LYZA TABLET
Marketing CategoryANDA
Application NumberANDA200980
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-01
Inactivation Date2020-01-31

NDC 53002-1687-3 [53002168703]

LYZA TABLET
Marketing CategoryANDA
Application NumberANDA200980
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-01
Inactivation Date2020-01-31

NDC 53002-1687-6 [53002168706]

LYZA TABLET
Marketing CategoryANDA
Application NumberANDA200980
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
NORETHINDRONE.35 mg/1

OpenFDA Data

SPL SET ID:5ce0eb18-6e34-4ec0-982b-2bddac311404
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1430383
  • 198042
  • 748961
  • Pharmacological Class

    • Progesterone Congeners [CS]
    • Progestin [EPC]

    NDC Crossover Matching brand name "LYZA" or generic name "Norethindrone"

    NDCBrand NameGeneric Name
    50102-100LYZAnorethindrone
    53002-1687LYZAnorethindrone
    51862-102CamilaNorethindrone
    51862-884CAMILANORETHINDRONE
    16714-440DEBLITANENorethindrone
    0555-0344ErrinNorethindrone
    51862-100ErrinNorethindrone
    51862-886ERRINNORETHINDRONE
    57297-877Jencyclanorethindrone
    52544-892JolivetteNORETHINDRONE
    50102-300LyleqNORETHINDRONE
    53002-1793LyleqNORETHINDRONE
    52544-629Nora BENorethindrone
    0378-7272NorethindroneNorethindrone
    0378-7292NORETHINDRONEnorethindrone
    50090-2150NorethindroneNorethindrone
    50090-6161NORETHINDRONENORETHINDRONE
    57297-876NORETHINDRONENORETHINDRONE
    63187-748NorethindroneNorethindrone
    42291-650Norethindrone AcetateNorethindrone
    50268-602Norethindrone AcetateNorethindrone
    50090-3235Norlydanorethindrone
    51660-127NORLYROCnorethindrone
    50458-194Ortho MicronorNORETHINDRONE
    16714-441SHAROBELNorethindrone
    50102-200TulanaNORETHINDRONE
    53002-2687TulanaNORETHINDRONE

    Trademark Results [LYZA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    LYZA
    LYZA
    85879467 4523185 Live/Registered
    Afaxys, Inc.
    2013-03-18
    LYZA
    LYZA
    77674711 not registered Dead/Abandoned
    Afaxys, Inc.
    2009-02-20
    LYZA
    LYZA
    77296222 3644281 Dead/Cancelled
    EYERIS, INC.
    2007-10-04

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.